US Capitol Capsule: Will sequester leave NIH NCATS weak as a kitten?
This article was originally published in Scrip
The National Institutes of Health (NIH) stands to lose more than $2.5 billion from its fiscal year 2013 discretionary spending dollars, plus another $11 million trimmed from it mandatory spending budget, if Congress does nothing to stop the so-called sequestration across-the-board cuts from taking effect in January, the White House Office of Management and Budget (OMB) said on 14 September, with other agencies, like the FDA, also taking critical hits to their purses.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.